Home  |  Contact

UniProtKB/Swiss-Prot Q14118: Variant p.Thr192Met

Dystroglycan
Gene: DAG1
Variant information

Variant position:  192
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Type of variant:  LP/P [Disclaimer]
The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change:  From Threonine (T) to Methionine (M) at position 192 (T192M, p.Thr192Met).
Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.

Physico-chemical properties:  Change from medium size and polar (T) to medium size and hydrophobic (M)
The physico-chemical property of the reference and variant residues and the change implicated.

BLOSUM score:  -1
The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description:  In MDDGC9; results in impaired interaction with LARGE1 and incomplete DAG1 glycosylation.
Any additional useful information about the variant.

Other resources:  
Links to websites of interest for the variant.



Sequence information

Variant position:  192
The position of the amino-acid change on the UniProtKB canonical protein sequence.

Protein sequence length:  895
The length of the canonical sequence.

Location on the sequence:   PDPGEVVSSACAADEPVTVL  T VILDADLTKMTPKQRIDLLH
The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.

Residue conservation: 
The multiple alignment of the region surrounding the variant against various orthologous sequences.

Human                         PDPGEVVSSACAADEPVTVLTVILDADLTKMTPKQRIDLLH

                              PDPAEVVSSACAADEPVTVLTVILDADLTKMTPKQRIDLLH

Mouse                         SDPGEVVPSACAADEPVTVLTVILDADLTKMTPKQRIDLLN

Pig                           PDPGEVVSSVCAADEPVTVLTVILDADLTKMIPKQRLDLLQ

Bovine                        PDPGEVVSLVCAADEPVTVLTVILDADLTKMTPKQRIDLLR

Rabbit                        PDLGEAAASACAAEEPVTVLTVILDADLTKMTPKQRIDLLH

Sequence annotation in neighborhood:  
The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.

TypePositionsDescription
Chain 30 – 653 Alpha-dystroglycan
Region 30 – 408 Required for laminin recognition
Region 169 – 200 O-glycosylated at one site
Disulfide bond 182 – 264
Beta strand 188 – 196


Literature citations

A dystroglycan mutation associated with limb-girdle muscular dystrophy.
Hara Y.; Balci-Hayta B.; Yoshida-Moriguchi T.; Kanagawa M.; Beltran-Valero de Bernabe D.; Gundesli H.; Willer T.; Satz J.S.; Crawford R.W.; Burden S.J.; Kunz S.; Oldstone M.B.; Accardi A.; Talim B.; Muntoni F.; Topaloglu H.; Dincer P.; Campbell K.P.;
N. Engl. J. Med. 364:939-946(2011)
Cited for: INVOLVEMENT IN MDDGC9; VARIANT MDDGC9 MET-192; CHARACTERIZATION OF VARIANT MDDGC9 MET-192;

Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.